TY  - RPRT
TI  - Combination CDC-like kinase inhibition (CLK)/Dual-specificity tyrosine-regulated kinase (DYRK) and taxane therapy in CTNNB1-mutated endometrial cancer
AU  - Corr, B. R.
AU  - Moroney, M. R.
AU  - Woodruff, E. R.
AU  - Watson, Z. L.
AU  - Jordan, K. R.
AU  - Danhorn, T.
AU  - Bailey, C.
AU  - Wolsky, R. J.
AU  - Bitler, B. G.
PY  - 2023
DO  - 10.1101/2023.04.04.535570
UR  - https://www.biorxiv.org/content/10.1101/2023.04.04.535570v1
ID  - 10.1101/2023.04.04.535570
ER  -